Literature DB >> 31359250

The Utility of CSF Xpert MTB/RIF in Diagnosis of Tubercular Meningitis in Children.

Jyothy A1, Vinod H Ratageri2, Shivanand Illalu1, S R Fattepur1, P K Wari1.   

Abstract

OBJECTIVE: To determine the utility of CSF Xpert MTB/RIF (GeneXpert) in diagnosis of tubercular meningitis in children in the age group of 2 mo to 12 y.
METHODS: This hospital based prospective observational study was conducted at Department of Pediatrics, Karnataka Institute of Medical Sciences (KIMS), Hubli from December 2015 through November 2016. All children with clinically suspected tuberculous meningitis (TBM) were included in the study. These children underwent a detailed history taking, clinical examination, blood investigations, lumbar puncture and CT brain. Cerebrospinal fluid (CSF) samples were sent for CSF GeneXpert examination. Statistical analysis was done using IBM SPSS Statistics Version 20.
RESULTS: A total of 28 children were enrolled in the study. Six (21.4%), 4 (14.3%) and 18 (64.3%) cases were definite, probable and possible TBM cases respectively. Most common age group affected was <5 y (83.33%) with median age 2.5 y (IQR 4.875). Male:female ratio was 1.5:1. CSF GeneXpert was tested positive in 6 cases (21.4%). The sensitivity of the test against the clinical scoring (>/=10) was 46.15% (95% CI, 19.22-74.87) and specificity was 100% (95% CI, 78.20-100). There was a significant association between CSF GeneXpert and Mantoux test (P = 0.002), CSF cell type >50% lymphocytes (P = 0.005) and CSF protein >100 mg/dl (P = 0.025) along with CT hydrocephalus (P = 0.021), granuloma (P = 0.009) and basal exudates (P = 0.025). None of the cases were tested smear positive for acid-fast bacilli (AFB).
CONCLUSIONS: CSF GeneXpert is superior to smear for AFB in TBM.

Entities:  

Keywords:  CSF; Children; Clinical score; TBM; Xpert MTB/RIF

Mesh:

Year:  2019        PMID: 31359250     DOI: 10.1007/s12098-019-03032-0

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  19 in total

Review 1.  Tuberculous meningitis: the challenges.

Authors:  J M K Murthy
Journal:  Neurol India       Date:  2010 Sep-Oct       Impact factor: 2.117

2.  Improved diagnosis of childhood tuberculous meningitis using more than one nucleic acid amplification test.

Authors:  R S Solomons; D H Visser; S O Friedrich; A H Diacon; K G P Hoek; B J Marais; J F Schoeman; A M van Furth
Journal:  Int J Tuberc Lung Dis       Date:  2015-01       Impact factor: 2.373

Review 3.  Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome.

Authors:  Flavia Brancusi; Jeremy Farrar; Dorothee Heemskerk
Journal:  Future Microbiol       Date:  2012-09       Impact factor: 3.165

4.  CT of the brain in tuberculous meningitis. A review of 289 patients.

Authors:  M Ozateş; S Kemaloglu; F Gürkan; U Ozkan; S Hoşoglu; M M Simşek
Journal:  Acta Radiol       Date:  2000-01       Impact factor: 1.990

5.  Central nervous system tuberculosis in children: a review of 214 cases.

Authors:  A Yaramiş; F Gurkan; M Elevli; M Söker; K Haspolat; G Kirbaş; M A Taş
Journal:  Pediatrics       Date:  1998-11       Impact factor: 7.124

6.  Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa.

Authors:  Gijs T J van Well; Berbe F Paes; Caroline B Terwee; Priscilla Springer; John J Roord; Peter R Donald; A Marceline van Furth; Johan F Schoeman
Journal:  Pediatrics       Date:  2009       Impact factor: 7.124

7.  Clinical presentations, diagnosis, mortality and prognostic markers of tuberculous meningitis in Vietnamese children: a prospective descriptive study.

Authors:  Nguyen Duc Bang; Maxine Caws; Thai Thanh Truc; Tran Ngoc Duong; Nguyen Huy Dung; Dang Thi Minh Ha; Guy E Thwaites; Doortje Heemskerk; Joel Tarning; Laura Merson; Pham Van Toi; Jeremy J Farrar; Marcel Wolbers; Thomas Pouplin; Jeremy N Day
Journal:  BMC Infect Dis       Date:  2016-10-18       Impact factor: 3.090

8.  Rapid Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in HIV-Infected Patients. Comparison of LED Fluorescent Microscopy and the GeneXpert MTB/RIF Assay in a District Hospital in India.

Authors:  Gerardo Alvarez-Uria; Jose M Azcona; Manoranjan Midde; Praveen K Naik; Srinivasulu Reddy; Raghuprakash Reddy
Journal:  Tuberc Res Treat       Date:  2012-08-26

9.  Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study.

Authors:  Vinod B Patel; Grant Theron; Laura Lenders; Brian Matinyena; Cathy Connolly; Ravesh Singh; Yacoob Coovadia; Thumbi Ndung'u; Keertan Dheda
Journal:  PLoS Med       Date:  2013-10-22       Impact factor: 11.069

10.  Tubercular meningitis in children: Clinical, pathological, and radiological profile and factors associated with mortality.

Authors:  Anil V Israni; Divya A Dave; Anirban Mandal; Amitabh Singh; Puneet K Sahi; Rashmi Ranjan Das; Arpita Shah
Journal:  J Neurosci Rural Pract       Date:  2016 Jul-Sep
View more
  4 in total

1.  Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Mandy Yao; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

Review 2.  Diagnostic Accuracy of Interferon-Gamma Release Assays for Tuberculous Meningitis: A Systematic Review and Meta-Analysis.

Authors:  An Wen; Er-Ling Leng; Shi-Min Liu; Yong-Liang Zhou; Wen-Feng Cao; Dong-Yuan Yao; Fan Hu
Journal:  Front Cell Infect Microbiol       Date:  2022-04-22       Impact factor: 6.073

3.  Risk factors for poor outcome in childhood tuberculous meningitis.

Authors:  Mao-Shui Wang; Mei Zhao; Xin-Jie Liu
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

4.  Cerebrospinal fluid Gene XPERT (CBNAAT) in children with tuberculous meningitis.

Authors:  Annapurna Rai; Rajniti Prasad; B K Das; Shampa Anupurba; Utpal Kant Singh
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.